Acticare
asserts that TSE is most beneficial for chronic conditions, especially for post-operative pain and patients experiencing neurogenic pain. Acticare
conducted a survey to investigate the extent of pain relief in 150 patients using
the TSE device, with an average age of 65 years and an average pain duration of
9.5 years. The survey results showed that 79% of the patients experienced 50%
or greater pain relief after using the device (Acticare, 2006). Based on these
results and other investigations, the following indications are presented in
the Acticare TSE user manual (http://www.acticare.com/docs/Acticare_TSE_manual.pdf).
- Back
pain
- Arthritis
- Persistent
neck pains
- Headaches
- Migraine
- Old
injuries
- Cervical
and lumbar spondylosis
- Insomnia
- Period
pains
- Chronic
pancreatitis
- Fibromyalgia
- Burnt
out rheumatoid arthritis
- Osteoporosis
Pain due to muscle spasm
- Post
mastectomy pain
- Sciatica
- Post
Shingles pain
- Stress
- Neuralgia
Contraindications &
Precautions
The
contraindications and precautions for using TSE are very similar to other
electrotherapy devices, which are most commonly patients with pacemakers,
metallic implants, epilepsy and patients which are pregnant (Acticare User Manual 2006).
Acticare states the following contraindications and precautions for use of TSE.
Contraindications
|
Precautions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Safety
The Acticare TSE device is built
in accordance with international electrotechnical commission (IEC) medical
devices standard 60601-2-10: Particular requirements for the safety of nerve
and muscle stimulators. Acticare pledges that the device is intrinsically safe
and thus cannot generate an unsafe sustained current or pulse charges. Acticare
also states that it has been used by 14000 patients with no reported serious
side effects or adverse reactions with medications. However its user manual
does warn the potential of adverse reactions such as skin irritation,
electrolysis and adverse effects which may include the following:
- Nausea
- General malaise
- Vomiting
- Fainting
- Headaches/migraines
- Epileptic seizure
- Tinnitus
- Numbness
- Loss of muscle tone
- Swelling and redness
References
1)
Acticare: TSE notes for practitioners (2006). Retrieved from http://www.acticare.com/docs/SM-00040_TSE_Notes_Practitioner.pdf
1)
Acticare: User Manual (2006). Retrieved from http://www.acticare.com/docs/Acticare_TSE_manual.pdf
No comments:
Post a Comment